AASLD/EASL 2019 HCV Special Conference

Product not yet rated

The goal of the conference is to promote global elimination of hepatitis C infection. World leaders in the related disciplines will assemble to establish the current state of the science and public health challenges. The experts will then formulate the most effective future steps toward elimination.

Core Competencies:  

  • Medical Knowledge
  • Work in Interdisciplinary Teams
  • Apply Quality Improvement
  • Values/Ethics for Interpersonal Practice
  • Roles/Responsibilities
  • Teams and Teamwork

  

Program Chairs:  

  • Raymond T. Chung, MD, FAASLD
  • David L. Thomas, MD
  • Markus Cornberg, MD
  • Alessio M. Aghemo, MD, PhD

John W. Ward

Andrew M. Hill

Andrea Cox

Eleanor J. Barnes

Natasha Martin

Michael P. Manns

Alessio Aghemo

Norah A. Terrault

Dr. Norah Terrault is the Professor of Medicine and the Director of the Viral Hepatitis Center at the University of California San Francisco. She is recognized nationally and internationally for her work related to viral hepatitis, especially in the setting of liver transplantation.  She has authored more than 290 original articles, reviews and book chapters on viral hepatitis, including the recent AASLD Hepatitis B Treatment Guidelines. She has served as associate editor for Hepatology, is current Associate Editor for Hepatology Communications and a member of the AASLD HCV Guidance Committee. She is an investigator on several NIH-funded clinical studies in hepatitis B and C, as well as NASH and is an investigator on several ongoing clinical trials of novel therapies for patients with chronic liver diseases.

 

 

Hashem B. El-Serag

Raymond T. Chung

Markus Cornberg

Lisa I. Backus

Imam Waked

Francesco Negro

Jag Chhatwal

Marina Berenguer

David Wyles

Components visible upon registration.